Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
The current price of Merck & Co Inc in the market is 2 510,29 Kč, with a 24-hour trading volume of 23,7B Kč. The asset's market cap is 6,23T Kč, after moving 0.33% in the last day.
Tokenized Merck & Co Inc is trading at 2 495,68 Kč, with a tokenized market cap of 18,81M Kč and a 24-hour trading volume of 16,04M Kč. The tokenized asset has moved 0.66% in the past 24 hours.